Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Case

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Seminars in Perinatology|February 1, 1992
Statistics and clinical trials: relevant issues in fetal and neonatal drug trialsM O'Shea, L D Case
Seminars in Oncology|September 1, 1986
Small-cell lung cancer: a 10-year perspectiveD V Jackson, L D Case
Lifetime Data Analysis|April 3, 2001
Duration of accrual and follow-up for two-stage clinical trialsL D Case, T M Morgan
Controlled Clinical Trials|June 1, 1987
Optimal restricted two-stage designsL D Case, T M Morgan, C E Davis
Anesthesiology|July 1, 1992
Trust, but verify. The accuracy of references in four anesthesia journalsM F McLellan, L D Case, M C Barnett
Archives of Internal Medicine|August 1, 1992
Mortality in intensive care patients with respiratory disease. Is age important?M D Heuser, L D Case, W H Ettinger
JAMA|July 1, 1992
Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience [see comment]K Christman, H B Muss, L D Case, et al.
Cancer|June 1, 1991
A comparison of treatment outcomes for black patients and white patients with metastatic breast cancer. The Piedmont Oncology Association experienceG Kimmick, H B Muss, L D Case, et al.
Breast Cancer Research and Treatment|February 1, 1997
Tamoxifen as initial endocrine therapy for metastatic breast cancer: long term follow-up of two Piedmont Oncology Association (POA) trialsJ T Kuss, H B Muss, H Hoen, et al.
Health Education Research|October 6, 1999
Receptivity of a worksite breast cancer screening education programE D Paskett, K B Masten, K C Phillips, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Seminars in Perinatology|February 1, 1992
Statistics and clinical trials: relevant issues in fetal and neonatal drug trialsM O'Shea, L D Case
Seminars in Oncology|September 1, 1986
Small-cell lung cancer: a 10-year perspectiveD V Jackson, L D Case
Lifetime Data Analysis|April 3, 2001
Duration of accrual and follow-up for two-stage clinical trialsL D Case, T M Morgan
Controlled Clinical Trials|June 1, 1987
Optimal restricted two-stage designsL D Case, T M Morgan, C E Davis
Anesthesiology|July 1, 1992
Trust, but verify. The accuracy of references in four anesthesia journalsM F McLellan, L D Case, M C Barnett
Archives of Internal Medicine|August 1, 1992
Mortality in intensive care patients with respiratory disease. Is age important?M D Heuser, L D Case, W H Ettinger
JAMA|July 1, 1992
Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience [see comment]K Christman, H B Muss, L D Case, et al.
Cancer|June 1, 1991
A comparison of treatment outcomes for black patients and white patients with metastatic breast cancer. The Piedmont Oncology Association experienceG Kimmick, H B Muss, L D Case, et al.
Breast Cancer Research and Treatment|February 1, 1997
Tamoxifen as initial endocrine therapy for metastatic breast cancer: long term follow-up of two Piedmont Oncology Association (POA) trialsJ T Kuss, H B Muss, H Hoen, et al.
Health Education Research|October 6, 1999
Receptivity of a worksite breast cancer screening education programE D Paskett, K B Masten, K C Phillips, et al.
Pageof 8